This inventor holds 35 USPTO granted patents and 28 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Peptidomimetic Macrocycles. Top assignees: Aileron Therapeutics, Inc., Alleron Therapeutics, Inc., Cold Spring Harbor Laboratory. Active years: 2001-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2001 - 2008)
- Concord, MA (US) (2011 - 2019)
- Lexington, MA (US) (2015 - 2021)
Company Filing History:
24 out of 44 
2 out of 2 
2 out of 197 
Years Active: 2001-2021
Areas of Expertise:
Title: Huw M Nash: Innovator in Antisense Oligomer Therapeutics
Introduction: Huw M Nash is a prominent inventor based in Concord, MA, recognized for his significant contributions to the field of biotechnology. With an impressive portfolio of 35 patents, Nash focuses on developing innovative methods and compositions aimed at improving protein expression for therapeutic applications.
Latest Patents: Among his latest patents, two noteworthy inventions include therapies employing antisense oligomers. The first patent details methods for increasing the expression of proteins in subjects with deficient protein expression or specific diseases. The second patent addresses treatments for Autosomal Dominant Mental Retardation-5 and Dravet Syndrome, providing methods for treating individuals with deficient SYNGAP1 or SCN1A protein expression.
Career Highlights: Throughout his career, Nash has played pivotal roles in notable biotechnology companies, including Aileron Therapeutics, Inc. and Alleron Therapeutics, Inc. His work is characterized by a commitment to advancing therapeutic approaches that tackle unmet medical needs, particularly in genetic and developmental disorders.
Collaborations: Nash has collaborated with esteemed colleagues such as Tomi K Sawyer and Noriyuki Kawahata. These partnerships highlight the collaborative spirit prevalent in the research community, essential for driving innovative solutions in complex scientific fields.
Conclusion: Huw M Nash stands as a significant figure in the biotech industry, with a dedicated focus on antisense therapies that hold promise for improving the lives of individuals with genetic disorders. His inventions and ongoing contributions to the field underscore the vital role of innovation in healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile